Huang Xi, Hong Yu, Xie Si-Ya, Liao Hui-Li, Huang Hao-Ming, Liu Jian-Hong, Long Wen-Jie
Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong Province, China.
Department of Chinese Internal Medicine, The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong Province, China.
World J Clin Cases. 2022 Oct 6;10(28):10317-10325. doi: 10.12998/wjcc.v10.i28.10317.
Malignant peritoneal mesothelioma (MPM) is an extremely rare tumor with nonspecific clinical manifestations, which is extremely difficult to diagnose. Herein, we reported a case of MPM in the abdominal cavity with massive short-term ascites as the first symptom.
A 65-year-old woman presented to the hospital with abdominal pain, distention, and shortness of breath that persisted for 15 d. The serum CA-125 level was 1075 U/mL. The abdominal computed tomography showed massive ascites and no obvious tumor lesions. The pathological examination of the ascitic fluid showed numerous heterotypic cells with some papillary structures. The immunohistochemistry and fluorescence hybridization showed the deletion of CDX2 (-), WT-1 (-), Ki-67 (about 10% +), CEA (-), Glut-1 (+++), desmin (-), PD-L1 (-), and CDKN2A (P16). The final diagnosis was MPM. The patient refused tumor cytoreductive surgery and received two cycles of cisplatin plus pemetrexed bidirectional chemotherapy. In the second cycle, she received an additional cycle of hyperthermic intraperitoneal chemotherapy and immune checkpoint inhibitor therapy due to massive recalcitrant ascites. She died of disease progression 2 mo after diagnosis.
In case of massive unexplained ascites, the possibility of MPM should not be excluded to avoid misdiagnosis and delay in treatment.
恶性腹膜间皮瘤(MPM)是一种极为罕见的肿瘤,临床表现不具特异性,诊断极具难度。在此,我们报告一例以大量短期腹水为首发症状的腹腔MPM病例。
一名65岁女性因腹痛、腹胀及呼吸困难持续15天入院。血清CA-125水平为1075 U/mL。腹部计算机断层扫描显示大量腹水且无明显肿瘤病灶。腹水病理检查发现大量异型细胞并伴有一些乳头状结构。免疫组织化学及荧光杂交显示CDX2(-)、WT-1(-)、Ki-67(约10% +)、CEA(-)、Glut-1(+++)、结蛋白(-)、PD-L1(-)及CDKN2A(P16)缺失。最终诊断为MPM。患者拒绝肿瘤细胞减灭术,接受了两周期顺铂联合培美曲塞双向化疗。在第二周期,因大量顽固性腹水,她额外接受了一周期热灌注腹腔化疗及免疫检查点抑制剂治疗。她在诊断后2个月因疾病进展死亡。
对于出现大量不明原因腹水的情况,不应排除MPM的可能性,以免误诊及延误治疗。